Company of the week: Enamine Ltd.

While working with General Proximity where we explored libraries of modifier proteins as potential therapies via induced proximity that subsequently enable post translational modifications (PTM), I found that Enamine Ltd. products and services were unmatched.

Enamine is a no-brainer for synthetic molecules, whether you need a wide range of analogues based on successful compounds or unique heterobifunctional molecules with exceptional potency and specificity, even if they require intricate synthesis processes. Not to mention their recent steps into enabling DNA-encoded Library (DEL) synthesis. Check out this post by TapBioscience to learn more about DEL - https://lnkd.in/gGp3Cgbf

The team is dedicated and overcome numerous challenges, including the complexity of synthesizing molecules derived from the world's largest chemical libraries. Despite external difficulties like the war in Ukraine, Enamine's operations persist. I recall seeing pictures of their dedicated teams, including sales, directors, computational biologists, and principal scientists, working in tunnels to ensure uninterrupted operations. Specifically Ivan Kondratov, Petro Borysko, Andrii Buvailo πŸ‡ΊπŸ‡¦, Yurii Moroz, and many more! Sending all love to you πŸ’ͺπŸ™

Enamine Ltd. boasts the world's largest reputable collection of chemical compounds, meticulously designed and produced for the Life Science industries. They offer an impressive stock collection comprising 4 million screening compounds, over 200,000 fragments, and more than 250,000 building blocks. Their comprehensive services encompass lead discovery with optimization, which include on-site integrated biomolecular and ADME/TOX screening.

I learn a lot about trends in biopharma just by checking out their website on a regular basis, researching their newest products, and following their press releases. Please take a gander at the website if you have made it to the end of this long post - https://enamine.net

If you are curious about anything in this post and would like to discuss further, contact me at TapBioscience!

Previous
Previous

Press with Cube Biotech